Fed. Circ. Urged To Review Toss Of Fetal DNA Test Patent
The Federal Circuit's recent determination that Sequenom Inc.'s fetal DNA test patent is invalid because it involves natural material poses an "existential threat" to patent production in multiple fields of invention,...To view the full article, register now.
Already a subscriber? Click here to view full article